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We compliment Dr Müller and colleagues [1] for their 
experiment on the protective role of simvastatin against 
ventilator-induced lung injury (VILI). Th   eir results are in 
line with those of a relevant study published recently by 
our research team; we also showed that pretreatment 
with statins (speciﬁ  cally atorvastatin) attenuates VILI [2]. 
By synthesizing the ﬁ  ndings of the above contributions 
[1,2], one could make several points.
First, given that Müller and colleagues administered 
simvastatin [1] while we chose atorvastatin [2], it seems 
that the observed beneﬁ  t is a class-speciﬁ  c rather than a 
drug-speciﬁ  c eﬀ  ect; that is, it may apply to the whole 
class of statins. Second, the prevention of VILI by statins 
seems not to be species-speciﬁ  c; indeed, our colleagues 
employed mice [1], while we preferred rabbits [2]. Th  ird, 
while the ﬁ   rst study used female animals [1] and the 
second study used male animals [2], there were no 
diﬀ  erences in the produced results; thus, statins seem to 
be useful for the prevention of VILI in both sexes. Th  is 
observation is important given the ongoing interest in 
the possibility that drug responses may diﬀ  er by sex [3]. 
Fourth, by using diﬀ  erent markers, both studies noted 
that administration of statins reduced VILI-associated 
hyperpermeability [1,2]. Indeed, the German group [1] 
used as a marker of lung permeability the human-serum-
albumin bronchoalveolar lavage/plasma ratio, while we 
used both lung edema and ultraﬁ  ltration  coeﬃ   cient 
(Kf,c). Finally, Müller and colleagues implemented a 
6-hour model of injurious mechanical ventilation to show 
that statins ameliorate pulmonary inﬂ  ammation  [1], 
whereas we focused on the very acute phase of lung 
injury, when mechanical phenomena rather than 
inﬂ  ammation may best explain the injury [2].
In conclusion, we believe that the two papers [1,2] 
combined provide strong experimental evidence that a 
dose of statin as high as 20 mg/kg body weight 
administered before the induction of mechanical 
ventilation may protect against VILI and relevant clinical 
trials are thus fully justiﬁ  ed.
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